SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-006336
Filing Date
2021-01-21
Accepted
2021-01-21 16:47:27
Documents
17
Period of Report
2021-01-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213310d4_8k.htm   iXBRL 8-K 31480
2 EXHIBIT 1.1 tm213310d4_ex1-1.htm EX-1.1 171003
3 EXHIBIT 5.1 tm213310d4_ex5-1.htm EX-5.1 11652
4 EXHIBIT 99.1 tm213310d4_ex99-1.htm EX-99.1 8911
8 GRAPHIC tm213310d4_ex5-1img001.jpg GRAPHIC 12084
9 GRAPHIC tm213310d4_ex99-1img001.jpg GRAPHIC 7948
  Complete submission text file 0001104659-21-006336.txt   471903

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA edit-20210120.xsd EX-101.SCH 3205
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE edit-20210120_lab.xml EX-101.LAB 34592
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edit-20210120_pre.xml EX-101.PRE 22723
10 EXTRACTED XBRL INSTANCE DOCUMENT tm213310d4_8k_htm.xml XML 3490
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 21542601
SIC: 2836 Biological Products, (No Diagnostic Substances)